1.Retroperitoneal Cyst.
Jin Chang SO ; Chung Ro LEE ; Il Yup CHOI
Korean Journal of Urology 1981;22(6):646-648
The retroperitoneal space is that indefinite area in the lumber and iliac region which lies between the peritoneum and the posterior wall of the abdominal cavity. The term retroperitoneal cyst or tumor is usually confined by the pathologist to these arising from the structures situated in the retroperitoneal space. Retroperitoneal cysts are that of non-neoplastic nature and originated from retroperitoneal tumor Because the retroperitoneal space is rather extensive and adjacent organs are easily displaced, many of the cysts grow to a large size before giving any clinical manifestation. Frequently, when the patient is first seen, there is an indefinite abdominal mass the exact nature of which is obscure, and the diagnosis is not made until the time of surgical investigation.
Abdominal Cavity
;
Diagnosis
;
Humans
;
Peritoneum
;
Retroperitoneal Space
2.The Differentiation of HL-60 Cells Causes to Lose their Ability to Express TNF mRNA.
Jung Hyun KIM ; Soo Jin HAN ; Choon Sik PARK ; Il Yup CHUNG
Korean Journal of Immunology 1999;21(1):47-53
It is well known that HL-60 cell, a human promyelocytic line, is differentiated into eosinophil-like cells in the presence of butyric acid, and thus the differentiated HL-60 cells have been used as a model system to study irnmunological properties of peripheral eosinophils which are thought to be terminally differentiated. To study whether HL-60 cells alter their capability of expressing cytokines during differentiation to eosinophil-like cells, we examined TNF mRNA levels in HL-60 cells treated with butyric acid by Ribonuclease Protection Assay (RPA). HL-60 cells were incubated for 3 days in the presence of butyric acid (0.5 mM), and stimulated with PMA and lipopolysaccharide (LPS). The levels of TNF mRNA decreased by 50 % and 95 % upon one and two days of post-treatment of butyric acid, respectively. The decreased pattern in TNF mRNA levels was also observed in HL-60 cells that have been treated with retinoic acid known as an inducer for differentiation of them. In accordance with these results, prominent azurophilic granules typical in eosinophils appeared in the cytoplasm of the differentiated HL-60 cells. The decreased expression of TNF mRNA was not attributable to the presence of serum, since increasing concentrations of serum had no effect. Furthermore, interleukin-5 (IL-5), which is known to be involved in activation and trafficking of eosinophils in vivo and in vitro, failed to affect TNF mRNA production when it was used in place of butyric acid. These data suggest that the differentiated HL-60 cells may have immunological resemblance to eosinophils in that they weakly produce the cytokine mRNA.
Butyric Acid
;
Cytokines
;
Cytoplasm
;
Eosinophils
;
HL-60 Cells*
;
Humans
;
Interleukin-5
;
Ribonucleases
;
RNA, Messenger*
;
Tretinoin
3.Malignant Teratoma of Prostatic Gland.
Jin Chang SO ; Chung Ro LEE ; Il Yup CHOI
Korean Journal of Urology 1982;23(1):136-139
A teratoma is a true tumor which is composed of a variety of cell types representative of more than one germ layer. These neoplasms are principally encountered in the ovaries and testes. Rarely teratoma arises in the midline of the body such as anterior mediastinum, retroperitoneum, sacrococcygeal region, intracranial cavity, neck, and abdominal viscera, presumably from primitive sequestrated cell nests during embryogenesis. The teratoma is mostly benign in histology and biology, however, rarely cancer develops in preexisting benign cystic teratoma. The prostatic gland is an unusual site of the teratoma and so we report a case of teratoma which arose in the prostatic gland and underwent malignant change.
Biology
;
Embryonic Development
;
Female
;
Germ Layers
;
Mediastinum
;
Neck
;
Ovary
;
Pregnancy
;
Prostate
;
Sacrococcygeal Region
;
Teratoma*
;
Testis
;
Viscera
4.Hypereosinophilia-associated Diseases and the Therapeutic Agents in Development.
Hanyang Medical Reviews 2013;33(1):65-74
Eosinophil is one of the most enigmatic leukocytes that plays pleiotropic roles in initiation and propagation of inflammatory conditions, modulation of innate and adaptive immune responses, homeostasis, and remodeling and repair of diverse tissues in health and disease. Eosinophils arise from CD34+ hematopoietic cells in the bone marrow under the influence of transcription factors (C/EBPalpha and GATA-1) and hematopoietic cytokines (IL-5, IL-3, and GM-CSF). The unusually high numbers of eosinophils in blood and/or tissues, so-called hypereosinophilia, are often critically involved in pathophysiology of a wide variety of inflammatory diseases in many organs, including many allergic diseases (asthma, rhinitis, conjunctivitis, atopic dermatitis), gastrointestinal diseases (eosinophilic eosophagitis, ulcerative colitis, Crohn's disease, Duchenne's muscular dystrophy, idiopathic myositis), cancers (pancreas, bladder, liver, kidney, breast, melanoma, colon, glioblastoma, gastric, uterine, oral/nasal, lung), infectious diseases (helminth, bacteria, virus, fungi), transplantation rejection (lung, cardiac, corneal, skin, liver, and renal), reproduction, and autoimmune diseases. A dozen of therapeutic agents, notably including humanized anti-IL-5 monoclonal antibodies, that directly and indirectly target eosinophils have been developed and are studied extensively under clinical and preclinical trials. Some agents have been shown to have promising perspectives to hypereosinophilic diseases, especially against asthma exacerbations and hypereosinophilic syndromes. Further studies are required for discovery of the specific mechanisms of actions of the different eosinophil-targeted therapies, dosing strategies and treatment options with identification of biomarkers that can monitor and predict the responses.
Antibodies, Monoclonal
;
Asthma
;
Autoimmune Diseases
;
Bacteria
;
Bone Marrow
;
Breast
;
Colitis, Ulcerative
;
Colon
;
Communicable Diseases
;
Conjunctivitis, Allergic
;
Crohn Disease
;
Cytokines
;
Eosinophils
;
Gastrointestinal Diseases
;
Glioblastoma
;
Graft Rejection
;
Homeostasis
;
Humans
;
Hypereosinophilic Syndrome
;
Interleukin-3
;
Interleukin-5
;
Kidney
;
Leukocytes
;
Liver
;
Melanoma
;
Muscular Dystrophies
;
Organothiophosphorus Compounds
;
Reproduction
;
Rhinitis
;
Skin
;
Transcription Factors
;
Urinary Bladder
;
Viruses
;
Biomarkers
5.The radiologic findings of neurofibromatosis
Chong Ku CHUNG ; Kyu Il PARK ; Yup YOON ; Soon Yong KIM
Journal of the Korean Radiological Society 1986;22(4):469-473
Neurofibromatosis, or von Recklinghausen's disease, is a hereditary, harmartomatous disorder that primarilyinvolves neuroectoderm and mesoderm. The estimated incidence is 1 in 2,500 to 3,000 births. The clinical featuresare skin manifestations such as cafe-au-lait spots, skeletal manifestations primarily in volving vertebrae,central and peripheral nervous manifestations, and other associated abnormalities with increased risk ofmalignancy. The authors analysed the radiologic findings of 18 cases of patients with neurofibromatosis whovisited Pusan Kosin Medical Center and Taegu Dongsan Medical Center during the last five years. All were proven bysurgery, biopsy and other diagnostic criteria. The results obtained were as follows: 1. The male ot female ratiowas 11:7 and the age ranged from 11 months to 51 years. 2. All the cases fulfilled the diagnotic criteria of Croweand associates. 3. Bone manifestations were present in 44% of the cases. The other radiologic findings wereintrathoracic meningocele, bilateral acoustic neurinomas, mediastinal or chest wall mass shadows, and peripheralsoft tissue masses. 4. One of the soft tissue masses was proved to be malignant.
Biopsy
;
Busan
;
Cafe-au-Lait Spots
;
Daegu
;
Female
;
Humans
;
Incidence
;
Male
;
Meningocele
;
Mesoderm
;
Neural Plate
;
Neurofibromatoses
;
Neurofibromatosis 1
;
Neurofibromatosis 2
;
Parturition
;
Skin Manifestations
;
Thoracic Wall
6.Eosinophil Development, Regulation of Eosinophil-Specific Genes, and Role of Eosinophils in the Pathogenesis of Asthma.
Tae Gi UHM ; Byung Soo KIM ; Il Yup CHUNG
Allergy, Asthma & Immunology Research 2012;4(2):68-79
Eosinophils arise from hematopoietic CD34+ stem cells in the bone marrow. They acquire IL-5Ralpha on their surface at a very early stage during eosinophilopoiesis, and differentiate under the strong influence of interleukin (IL)-5. They then exit to the bloodstream, and enter the lung upon exposure to airway inflammatory signals, including eotaxins. In inflamed tissues, eosinophils act as key mediators of terminal effector functions and innate immunity and in linking to adaptive immune responses. Transcription factors GATA-1, CCAAT/enhancer-binding protein, and PU.1 play instructive roles in eosinophil specification from multipotent stem cells through a network of cooperative and antagonistic interactions. Not surprisingly, the interplay of these transcription factors is instrumental in forming the regulatory circuit of expression of eosinophil-specific genes, encoding eosinophil major basic protein and neurotoxin, CC chemokine receptor 3 eotaxin receptor, and IL-5 receptor alpha. Interestingly, a common feature is that the critical cis-acting elements for these transcription factors are clustered in exon 1 and intron 1 of these genes rather than their promoters. Elucidation of the mechanism of eosinophil development and activation may lead to selective elimination of eosinophils in animals and human subjects. Furthermore, availability of a range of genetically modified mice lacking or overproducing eosinophil-specific genes will facilitate evaluation of the roles of eosinophils in the pathogenesis of asthma. This review summarizes eosinophil biology, focusing on development and regulation of eosinophil-specific genes, with a heavy emphasis on the causative link between eosinophils and pathological development of asthma using genetically modified mice as models of asthma.
Aluminum Hydroxide
;
Animals
;
Asthma
;
Biology
;
Bone Marrow
;
Carbonates
;
Eosinophil Major Basic Protein
;
Eosinophils
;
Exons
;
Humans
;
Immunity, Innate
;
Interleukin-5
;
Interleukins
;
Introns
;
Lung
;
Mice
;
Multipotent Stem Cells
;
Receptors, CCR3
;
Stem Cells
;
Transcription Factors
7.Radiologic Results in Accordance with the Number of Distal Locking Screws in Volar Plate Fixation for Distal Radius Fractures.
Hyun Chul CHOI ; Joo Yup LEE ; Joon Young JUNG ; Il Jung PARK ; Yang Guk CHUNG
Journal of the Korean Society for Surgery of the Hand 2014;19(3):124-129
PURPOSE: The purpose of this study was to determine whether the number of distal locking screws affected the final radiologic results after volar plate fixation for distal radius fractures. METHODS: We retrospectively identified 176 patients (male, 36; female, 140; average, 60 years) who had distal radius fractures treated with open reduction and volar plate fixation between 2011 and 2012. The number of screws used for distal fixation was determined according to the surgeon's preference and the type of plate used. Radiologic parameters and their displacements were measured postoperatively and at final follow-up. The results of using 4 or 5 distal locking screws were compared with those of using more than 6 distal locking screws. RESULTS: There was no significant displacement in fracture fragment when using 4 or 5 distal locking screws compared with using more than 6 distal locking screws. Mean displacement in ulnar variance was 0.6 mm in group with less than 5 screws, and the displacement was 0.4 mm in group with more than 6 screws (p=0.772). Secondary displacement was not correlated with fracture type or the number of distal locking screws. There was no fixation failure during the study period. CONCLUSION: It seems that 4 or 5 distal locking screws are strong enough to prevent a significant loss of fracture reduction. Filling every distal screw hole is not recommended to limit cost and avoid extensor tendon complications.
Female
;
Follow-Up Studies
;
Humans
;
Radius Fractures*
;
Retrospective Studies
;
Tendons
;
Palmar Plate*
8.Terminally Differentiating Eosinophils Express Neutrophil Primary Granule Proteins as well as Eosinophil-specific Granule Proteins in a Temporal Manner.
Karam KIM ; Sae Mi HWANG ; Sung Min KIM ; Sung Woo PARK ; Yunjae JUNG ; Il Yup CHUNG
Immune Network 2017;17(6):410-423
Neutrophils and eosinophils, 2 prominent granulocytes, are commonly derived from myelocytic progenitors through successive stages in the bone marrow. Our previous genome-wide transcriptomic data unexpectedly showed that genes encoding a multitude of neutrophil primary granule proteins (NPGPs) were markedly downregulated during the end period of eosinophilic terminal differentiation when cord blood (CB) cluster of differentiation (CD) 34+ cells were induced to differentiate toward the eosinophil lineage during a 24-day culture period. Accordingly, this study aimed to examine whether NPGP genes were expressed on the way to eosinophil terminal differentiation stage and to compare their expression kinetics with that of genes encoding eosinophil-specific granule proteins (ESGPs). Transcripts of all NPGP genes examined, including proteinase 3, myeloperoxidase, cathepsin G (CTSG), and neutrophil elastase, reached a peak at day 12 and sharply declined thereafter, while transcript of ESGP genes including major basic protein 1 (MBP1) attained maximum expression at days 18 or 24. Growth factor independent 1 (GFI1) and CCAAT/enhancer-binding protein α (C/EBPA), transactivators for the NPGP genes, were expressed immediately before the NPGP genes, whereas expression of C/EBPA, GATA1, and GATA2 kinetically paralleled that of eosinophil granule protein genes. The expression kinetics of NPGPs and ESGPs were duplicated upon differentiation of the eosinophilic leukemia cell line (EoL-1) immature eosinophilic cells. Importantly, confocal image analysis showed that CTSG was strongly coexpressed with MBP1 in differentiating CB eosinophils at days 12 and 18 and became barely detectable at day 24 and beyond. Our results suggest for the first time the presence of an immature stage where eosinophils coexpress NPGPs and ESGPs before final maturation.
Bone Marrow
;
Cathepsin G
;
Cell Line
;
Eosinophils*
;
Fetal Blood
;
Granulocytes
;
Hypereosinophilic Syndrome
;
Kinetics
;
Leukocyte Elastase
;
Myeloblastin
;
Neutrophils*
;
Peroxidase
;
Trans-Activators
9.The Usefulness of Computed Tomography in Distal Radius Fractures Involving Articular Surface.
Bae Gyun KIM ; Yang Guk CHUNG ; Joo Yup LEE ; Il Jung PARK ; Hyun Ho YOO
Journal of the Korean Society for Surgery of the Hand 2009;14(4):179-185
PURPOSE: To evaluate the usefulness of computed tomography(CT) scanning in classification and selection of treatment method for distal radius fractures involving articular surfaces. MATERIALS AND METHODS: Plain radiographs and CT scans of 42 patients with intraarticular distal radius fractures was analysed for type of fractures and surgical indication and then the results were compared. RESULTS: Fracture types were changed in 15 of 42 patients. 10 patients with AO B1, B3, C1 or C2 type fractures were reclassified as C3 type, which suggested that CT scan revealed articular comminution more accurately. According to the assesment of plain radiographs, 16 patient needed surgical treatment. However additional 17(68%) patients were necessary operation on the bases CT scan evaluation. CONCLUSIONS: Evaluation of intraarticular fractures of distal radius using CT scan was useful for fracture classification and selection of treatment methods, which provided an accurate assessment of fracture patterns and reduction status.
Equidae
;
Humans
;
Intra-Articular Fractures
;
Radius
;
Radius Fractures
10.Roles of RUNX1 and PU.1 in CCR3 Transcription.
Su Kang KONG ; Byung Soo KIM ; Sae Mi HWANG ; Hyune Hwan LEE ; Il Yup CHUNG
Immune Network 2016;16(3):176-182
CCR3 is a chemokine receptor that mediates the accumulation of allergic inflammatory cells, including eosinophils and Th2 cells, at inflamed sites. The regulatory sequence of the CCR3 gene, contains two Runt-related transcription factor (RUNX) 1 sites and two PU.1 sites, in addition to a functional GATA site for transactivation of the CCR3 gene. In the present study, we examined the effects of the cis-acting elements of RUNX1 and PU.1 on transcription of the gene in EoL-1 eosinophilic cells and Jurkat T cells, both of which expressed functional surface CCR3 and these two transcription factors. Introduction of RUNX1 siRNA or PU.1 siRNA resulted in a modest decrease in CCR3 reporter activity in both cell types, compared with transfection of GATA-1 siRNA. Cotransfection of the two siRNAs led to inhibition in an additive manner. EMSA analysis showed that RUNX1, in particular, bound to its binding motifs. Mutagenesis analysis revealed that all point mutants lacking RUNX1- and PU.1-binding sites exhibited reduced reporter activities. These results suggest that RUNX1 and PU.1 participate in transcriptional regulation of the CCR3 gene.
Eosinophils
;
Mutagenesis
;
RNA, Small Interfering
;
T-Lymphocytes
;
Th2 Cells
;
Transcription Factors
;
Transcriptional Activation
;
Transfection